Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisaveta Voynova

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunityElizabeth R Walsh, Prapaporn Pisitkun, Elisaveta Voynova, et al.
Cancers|February 15, 2022
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell LeukemiasElisaveta Voynova, Nga Hawk, Francis A Flomerfelt, et al.
International Immunology|December 25, 2007
Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptorNikolina Mihaylova, Elisaveta Voynova, Andrey Tchorbanov, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
The Journal of Clinical Investigation|April 4, 2018
Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus modelsSantosh K Panda, Valeria Facchinetti, Elisaveta Voynova, et al.
Molecular Medicine (Cambridge, Mass.)|December 25, 2015
Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response SyndromesIglika Djoumerska-Alexieva, Lubka Roumenina, Anastas Pashov, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2012
Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunityElizabeth R Walsh, Prapaporn Pisitkun, Elisaveta Voynova, et al.
Cancers|February 15, 2022
Increased Activity of a NK-Specific CAR-NK Framework Targeting CD3 and CD5 for T-Cell LeukemiasElisaveta Voynova, Nga Hawk, Francis A Flomerfelt, et al.
International Immunology|December 25, 2007
Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptorNikolina Mihaylova, Elisaveta Voynova, Andrey Tchorbanov, et al.
Leukemia|February 26, 2021
Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemiaDamian Kovalovsky, Jeong Heon Yoon, Matthew G Cyr, et al.
The Journal of Clinical Investigation|April 4, 2018
Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus modelsSantosh K Panda, Valeria Facchinetti, Elisaveta Voynova, et al.
Molecular Medicine (Cambridge, Mass.)|December 25, 2015
Intravenous Immunoglobulin with Enhanced Polyspecificity Improves Survival in Experimental Sepsis and Aseptic Systemic Inflammatory Response SyndromesIglika Djoumerska-Alexieva, Lubka Roumenina, Anastas Pashov, et al.
Pageof 2